|
2024
|
Invention
|
Minimally-invasive tools and methods for accessing the middle and inner ear through the tympanic ... |
|
|
Invention
|
Inner ear drug delivery devices and methods of use.
An implantable device for delivering a thera... |
|
|
P/S
|
Devices that facilitate the delivery of medication, namely, transdermal drug delivery patches sol... |
|
|
Invention
|
Devices, systems, and methods for treating ear disorders.
Systems and methods can be employed fo... |
|
2023
|
Invention
|
Visualization devices, systems, and methods for otology and other uses.
Devices, systems, and me... |
|
|
Invention
|
Systems and methods for treating hearing loss.
Systems and methods can be employed for trans-tym... |
|
2022
|
Invention
|
Cochlea injection devices, systems, and methods for otology.
Devices, systems, and methods can b... |
|
|
Invention
|
Cochlea injection devices, systems, and methods for otology. Devices, systems, and methods can be... |
|
|
Invention
|
Endoscopic systems and methods for treating hearing loss.
Systems and methods can be employed fo... |
|
|
Invention
|
Endoscopic systems and methods for treating hearing loss. Systems and methods can be employed for... |
|
|
Invention
|
Formulations for delivery to the ear.
Disclosed herein are polymer compositions comprising, in s... |
|
|
Invention
|
Systems and methods for treating hearing loss. Systems and methods can be employed for trans-tymp... |
|
|
Invention
|
Inner ear drug delivery devices and methods of use. An implantable device for delivering a therap... |
|
2021
|
Invention
|
Gelling solutions for administration of compounds to the inner ear.
Provided herein are polymer ... |
|
|
Invention
|
Gelling solutions for administration of compounds to the inner ear. Provided herein are polymer c... |
|
|
Invention
|
Treatment of otic diseases and conditions.
Active agents that bind to VEGF or a VEGF receptor an... |
|
|
Invention
|
Treatment of otic diseases and conditions. Active agents that bind to VEGF or a VEGF receptor and... |
|
|
Invention
|
Devices, systems, and methods for otology. Systems and methods can be employed for facilitating a... |
|
|
Invention
|
Visualization devices, systems, and methods for otology and other uses. Devices, systems, and met... |
|
|
Invention
|
Devices, systems, and methods for otology. Devices, systems, and methods can be employed to facil... |
|
|
Invention
|
Devices, systems, and methods for treating ear disorders. Systems and methods can be employed for... |
|
|
Invention
|
Devices, systems, and methods for otology.
Devices, systems, and methods can be employed to faci... |
|
|
Invention
|
Devices, systems, and methods for otology.
Systems and methods can be employed for facilitating ... |
|
2020
|
Invention
|
Treatments of meniere's disease.
Active agents that bind to VEGF or a VEGF receptor and reduce t... |
|
|
Invention
|
Treatments of meniere's disease. Active agents that bind to VEGF or a VEGF receptor and reduce th... |
|
|
Invention
|
Otic formulations for drug-induced ototoxicity.
Provided herein are methods for preventing and/o... |
|
|
Invention
|
Intratympanic injector devices and needles for delivery of drugs and methods of use. A system for... |
|
|
Invention
|
Apoptosis inhibitor formulations for prevention of hearing loss.
A formulation for sustained rel... |
|
|
Invention
|
Self-gelling solutions for administration of therapeutics to the inner ear.
A solution for susta... |
|
|
Invention
|
Self-gelling solutions for administration of therapeutics to the inner ear. in vitroin vivoin viv... |
|
2019
|
P/S
|
Pharmaceutical research and development; Research and development in the fields of hearing, speec... |
|
|
P/S
|
Pharmaceutical research and development; Research and development and consultation related theret... |
|
|
Invention
|
Apoptosis inhibitor formulations for prevention of hearing loss. A formulation for sustained rele... |
|
2010
|
Invention
|
Apaf-1 inhibitor compounds. Derivatives of 2,5-piperazinedione of formula (I) are apoptotic pepti... |
